Filing Details
- Accession Number:
- 0001209191-18-005638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-26 16:46:00
- Reporting Period:
- 2018-01-24
- Accepted Time:
- 2018-01-26 16:46:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-24 | 4,310 | $91.05 | 46,262 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-01-24 | 4,659 | $86.52 | 50,921 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-24 | 8,969 | $169.00 | 41,952 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-24 | 4,310 | $0.00 | 4,310 | $91.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-24 | 4,659 | $0.00 | 4,659 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,397 | 2026-02-01 | No | 4 | M | Direct | |
| 20,193 | 2027-02-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 2/2/2016.
- The option vests in 16 quarterly installments from 2/3/2017.
Billionaire Hedge Funds
